| 1 |
Mbatha LS, Akinyelu J, Chukwuma CI, Mokoena MP, Kudanga T. Current Trends and Prospects for Application of Green Synthesized Metal Nanoparticles in Cancer and COVID-19 Therapies. Viruses 2023;15:741. [DOI: 10.3390/v15030741] [Reference Citation Analysis]
|
| 2 |
Paul A, Chakraborty N, Sarkar A, Acharya K, Ranjan A, Chauhan A, Srivastava S, Singh AK, Rai AK, Mubeen I, Prasad R. Ethnopharmacological Potential of Phytochemicals and Phytogenic Products against Human RNA Viral Diseases as Preventive Therapeutics. Biomed Res Int 2023;2023:1977602. [PMID: 36860811 DOI: 10.1155/2023/1977602] [Reference Citation Analysis]
|
| 3 |
Dixit H, Upadhyay V, Kulharia M, Verma SK. The putative metal-binding proteome of the Coronaviridae family. Metallomics 2023;15:mfad001. [PMID: 36610727 DOI: 10.1093/mtomcs/mfad001] [Reference Citation Analysis]
|
| 4 |
Vengalasetti YV, Naderi N, Vega C, Kumar A, Catanzaro AT. COVID‐19: Immunology. Coronavirus Disease 2019 (COVID‐19) 2023. [DOI: 10.1002/9781119789741.ch6] [Reference Citation Analysis]
|
| 5 |
Aydin İC, Maytalman E, Gülpak ME. Drugs Used in Covid-19 Pandemic and Effects of Auranofin. Akd Tıp D 2023;9:90-97. [DOI: 10.53394/akd.953835] [Reference Citation Analysis]
|
| 6 |
Yadav M, Dhakla P, Rawat R, Dahiya M, Kumar A. Therapeutic Repurposing Approach: New Opportunity for Developing Drugs Against COVID-19. Drug Repurposing for Emerging Infectious Diseases and Cancer 2023. [DOI: 10.1007/978-981-19-5399-6_24] [Reference Citation Analysis]
|
| 7 |
Lei S, Chen X, Wu J, Duan X, Men K. Small molecules in the treatment of COVID-19. Signal Transduct Target Ther 2022;7:387. [PMID: 36464706 DOI: 10.1038/s41392-022-01249-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Lucignano R, Pratesi A, Imbimbo P, Monti DM, Picone D, Messori L, Ferraro G, Merlino A. Evaluation of Auranofin Loading within Ferritin Nanocages. Int J Mol Sci 2022;23. [PMID: 36430642 DOI: 10.3390/ijms232214162] [Reference Citation Analysis]
|
| 9 |
Verny J, Oulmakki O, Hernandez Meza A. Perspective Chapter: Gold Nanoparticles Market: A Global Overview and New Challenges in the Post-Pandemic Economy. Gold Nanoparticles and Their Applications in Engineering [Working Title] 2022. [DOI: 10.5772/intechopen.107071] [Reference Citation Analysis]
|
| 10 |
Azad AK, Islam MN, Chowdhury MAI, Kabir E. In Silico Testing of Some Protected Galactopyranose as SARS-CoV-2 Main Protease Inhibitors. J Appl Sci Process Eng 2022;9:1281-1294. [DOI: 10.33736/jaspe.4970.2022] [Reference Citation Analysis]
|
| 11 |
Laplantine E, Chable-Bessia C, Oudin A, Swain J, Soria A, Merida P, Gourdelier M, Mestiri S, Besseghe I, Bremaud E, Neyret A, Lyonnais S, Favard C, Benaroch P, Hubert M, Schwartz O, Guerin M, Danckaert A, Del Nery E, Muriaux D, Weil R. The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling. iScience 2022;25:105066. [PMID: 36093378 DOI: 10.1016/j.isci.2022.105066] [Reference Citation Analysis]
|
| 12 |
Pirola CJ, Sookoian S. Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait. Clin Mol Hepatol 2022;28:806-9. [PMID: 35989091 DOI: 10.3350/cmh.2022.0208] [Reference Citation Analysis]
|
| 13 |
Alegría-arcos M, Barbosa T, Sepúlveda F, Combariza G, González J, Gil C, Martínez A, Ramírez D. Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19. Front Pharmacol 2022;13:952192. [DOI: 10.3389/fphar.2022.952192] [Reference Citation Analysis]
|
| 14 |
Al-harbi SA. Synthesis and characterization of violurate - based Mn(II) and Cu(II) complexes nano-crystallites as DNA-binders and therapeutics agents against SARS-CoV-2 virus. Journal of Saudi Chemical Society 2022. [DOI: 10.1016/j.jscs.2022.101528] [Reference Citation Analysis]
|
| 15 |
Mushtaq A, Iqbal MZ, Kong X. Antiviral effects of coinage metal-based nanomaterials to combat COVID-19 and its variants. J Mater Chem B 2022;10:5323-43. [PMID: 35775993 DOI: 10.1039/d2tb00849a] [Reference Citation Analysis]
|
| 16 |
Abate C, Carnamucio F, Giuffrè O, Foti C. Metal-Based Compounds in Antiviral Therapy. Biomolecules 2022;12:933. [DOI: 10.3390/biom12070933] [Reference Citation Analysis]
|
| 17 |
Li H, Yuan S, Wei X, Sun H. Metal-based strategies for the fight against COVID-19. Chem Commun (Camb) 2022. [PMID: 35730442 DOI: 10.1039/d2cc01772e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 18 |
Abd El-Lateef HM, El-Dabea T, Khalaf MM, Abu-Dief AM. Development of Metal Complexes for Treatment of Coronaviruses. Int J Mol Sci 2022;23:6418. [PMID: 35742870 DOI: 10.3390/ijms23126418] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 19 |
Haftek M, Abdayem R, Guyonnet-Debersac P. Skin Minerals: Key Roles of Inorganic Elements in Skin Physiological Functions. Int J Mol Sci 2022;23:6267. [PMID: 35682946 DOI: 10.3390/ijms23116267] [Reference Citation Analysis]
|
| 20 |
Natekar JP, Pathak H, Stone S, Kumari P, Sharma S, Auroni TT, Arora K, Rothan HA, Kumar M. Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice. Viruses 2022;14:1139. [PMID: 35746611 DOI: 10.3390/v14061139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 21 |
Cheng XF, Wang N, Jiang Z, Chen Z, Niu Y, Tong L, Yu T, Tang B. Quantitative Chemoproteomic Profiling of Targets of Au(I) Complexes by Competitive Activity-Based Protein Profiling. Bioconjug Chem 2022. [PMID: 35576584 DOI: 10.1021/acs.bioconjchem.2c00080] [Reference Citation Analysis]
|
| 22 |
Fonseca C, Aureliano M. Biological Activity of Gold Compounds against Viruses and Parasitosis: A Systematic Review. BioChem 2022;2:145-159. [DOI: 10.3390/biochem2020010] [Reference Citation Analysis]
|
| 23 |
Ndugire W, Raviranga NGH, Lao J, Ramström O, Yan M. Gold Nanoclusters as Nanoantibiotic Auranofin Analogues. Adv Healthc Mater 2022;11:e2101032. [PMID: 34350709 DOI: 10.1002/adhm.202101032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 24 |
Natekar JP, Pathak H, Stone S, Kumari P, Sharma S, Arora K, Rothan HA, Kumar M. Differential pathogenesis of SARS-CoV-2 variants of concern in human ACE2-expressing mice.. [DOI: 10.1101/2022.04.04.486975] [Reference Citation Analysis]
|
| 25 |
Prabhu S, Vijayakumar S, Praseetha P. Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review. Chronic Diseases and Translational Medicine. [DOI: 10.1002/cdt3.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 26 |
Ioannou K, Vlasiou MC. Metal-based complexes against SARS-CoV-2. Biometals 2022. [PMID: 35332435 DOI: 10.1007/s10534-022-00386-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Gukathasan S, Awuah SG. Synthetic Strategies for the Preparation of Gold‐based Anticancer Agents. Encyclopedia of Inorganic and Bioinorganic Chemistry 2022. [DOI: 10.1002/9781119951438.eibc2822] [Reference Citation Analysis]
|
| 28 |
Guala D, Sonnhammer ELL. Network Crosstalk as a Basis for Drug Repurposing. Front Genet 2022;13:792090. [DOI: 10.3389/fgene.2022.792090] [Reference Citation Analysis]
|
| 29 |
Zoulikha M, He W. Targeted Drug Delivery for Chronic Lymphocytic Leukemia. Pharm Res. [DOI: 10.1007/s11095-022-03214-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Chawla K, Subramanian G, Rahman T, Fan S, Chakravarty S, Gujja S, Demchak H, Chakravarti R, Chattopadhyay S. Autophagy in Virus Infection: A Race between Host Immune Response and Viral Antagonism. Immuno 2022;2:153-69. [PMID: 35252965 DOI: 10.3390/immuno2010012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 31 |
Kiremitler NB, Kemerli MZ, Kayaci N, Karagoz S, Pekdemir S, Sarp G, Sanduvac S, Onses MS, Yilmaz E. Nanostructures for the Prevention, Diagnosis, and Treatment of SARS-CoV-2: A Review. ACS Appl Nano Mater 2022;5:6029-54. [DOI: 10.1021/acsanm.2c00181] [Reference Citation Analysis]
|
| 32 |
Aghamirza Moghim Aliabadi H, Eivazzadeh‐keihan R, Beig Parikhani A, Fattahi Mehraban S, Maleki A, Fereshteh S, Bazaz M, Zolriasatein A, Bozorgnia B, Rahmati S, Saberi F, Yousefi Najafabadi Z, Damough S, Mohseni S, Salehzadeh H, Khakyzadeh V, Madanchi H, Kardar GA, Zarrintaj P, Saeb MR, Mozafari M. COVID‐19: A systematic review and update on prevention, diagnosis, and treatment. MedComm 2022;3. [DOI: 10.1002/mco2.115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 33 |
Rothan HA, Kumari P, Stone S, Natekar JP, Arora K, Auroni TT, Kumar M. SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways. Pathogens 2022;11:257. [DOI: 10.3390/pathogens11020257] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 34 |
Wallis RS, Ginindza S, Beattie T, Arjun N, Likoti M, Sebe M, Edward VA, Rassool M, Ahmed K, Fielding K, Ahidjo BA, Vangu MDT, Churchyard G. Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial. PLoS ONE 2022;17:e0252097. [DOI: 10.1371/journal.pone.0252097] [Reference Citation Analysis]
|
| 35 |
Ni Y, Zeng H, Song X, Zheng J, Wu H, Liu C, Zhang Y. Potential metal-related strategies for prevention and treatment of COVID-19. Rare Met . [DOI: 10.1007/s12598-021-01894-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Yossief M, Singh V, Maydaniuk D, Cardona S, Kuss S. Electrochemical Characterization of the Repurposed Antimicrobial Compound Auranofin in Aqueous Solutions. Electroanalysis. [DOI: 10.1002/elan.202100378] [Reference Citation Analysis]
|
| 37 |
El-Aarag SA, Mahmoud A, ElHefnawi M. Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome. Int J Biol Macromol 2022;194:770-80. [PMID: 34826456 DOI: 10.1016/j.ijbiomac.2021.11.124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 38 |
Aitio A, Nordberg, M, Santonen T. Gold and Gold mining. Handbook on the Toxicology of Metals 2022. [DOI: 10.1016/b978-0-12-822946-0.00013-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Stone S, Rothan HA, Natekar JP, Kumari P, Sharma S, Pathak H, Arora K, Auroni TT, Kumar M. SARS-CoV-2 Variants of Concern Infect the Respiratory Tract and Induce Inflammatory Response in Wild-Type Laboratory Mice. Viruses 2021;14. [PMID: 35062231 DOI: 10.3390/v14010027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 40 |
Cirri D, Marzo T, Tolbatov I, Marrone A, Saladini F, Vicenti I, Dragoni F, Boccuto A, Messori L. In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study. Biomolecules 2021;11:1858. [PMID: 34944502 DOI: 10.3390/biom11121858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 41 |
Chen J, Ali F, Khan I, Zhu YZ. Recent progress in the development of potential drugs against SARS-CoV-2. Curr Res Pharmacol Drug Discov 2021;2:100057. [PMID: 34870155 DOI: 10.1016/j.crphar.2021.100057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Shen H, Xu C, Sun F, Zhao M, Wu Q, Zhang J, Li S, Zhang J, Lam JWY, Tang BZ. Metal-Based Aggregation-Induced Emission Theranostic Systems. ChemMedChem 2021. [PMID: 34837664 DOI: 10.1002/cmdc.202100578] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 43 |
Aherfi S, Pradines B, Devaux C, Honore S, Colson P, Scola B, Raoult D. Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV. Future Microbiol 2021;16:1341-70. [PMID: 34755538 DOI: 10.2217/fmb-2021-0019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 44 |
Gil-Moles M, Türck S, Basu U, Pettenuzzo A, Bhattacharya S, Rajan A, Ma X, Büssing R, Wölker J, Burmeister H, Hoffmeister H, Schneeberg P, Prause A, Lippmann P, Kusi-Nimarko J, Hassell-Hart S, McGown A, Guest D, Lin Y, Notaro A, Vinck R, Karges J, Cariou K, Peng K, Qin X, Wang X, Skiba J, Szczupak Ł, Kowalski K, Schatzschneider U, Hemmert C, Gornitzka H, Milaeva ER, Nazarov AA, Gasser G, Spencer J, Ronconi L, Kortz U, Cinatl J, Bojkova D, Ott I. Metallodrug Profiling against SARS-CoV-2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain-like Protease PLpro. Chemistry 2021. [PMID: 34714566 DOI: 10.1002/chem.202103258] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 45 |
Yamashita M. Auranofin: Past to Present, and repurposing. Int Immunopharmacol 2021;101:108272. [PMID: 34731781 DOI: 10.1016/j.intimp.2021.108272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 46 |
Sonzogni-Desautels K, Ndao M. Will Auranofin Become a Golden New Treatment Against COVID-19? Front Immunol 2021;12:683694. [PMID: 34630379 DOI: 10.3389/fimmu.2021.683694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 47 |
Glanz A, Chakravarty S, Fan S, Chawla K, Subramanian G, Rahman T, Walters D, Chakravarti R, Chattopadhyay S. Autophagic degradation of IRF3 induced by the small-molecule auranofin inhibits its transcriptional and proapoptotic activities. J Biol Chem 2021;297:101274. [PMID: 34619149 DOI: 10.1016/j.jbc.2021.101274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 48 |
Stone S, Rothan HA, Natekar JP, Kumari P, Sharma S, Pathak H, Arora K, Auroni TT, Kumar M. SARS-CoV-2 variants of concern infect the respiratory tract and induce inflammatory response in wild-type laboratory mice.. [DOI: 10.1101/2021.09.29.462373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 49 |
Christie MJ, Irving AT, Forster SC, Marsland BJ, Hansbro PM, Hertzog PJ, Nold-Petry CA, Nold MF. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. Sci Immunol 2021;6:eabd0205. [PMID: 34533977 DOI: 10.1126/sciimmunol.abd0205] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 50 |
Seifi T, Reza Kamali A. Antiviral performance of graphene-based materials with emphasis on COVID-19: A review. Med Drug Discov 2021;11:100099. [PMID: 34056572 DOI: 10.1016/j.medidd.2021.100099] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 51 |
Biji A, Khatun O, Swaraj S, Narayan R, Rajmani RS, Sardar R, Satish D, Mehta S, Bindhu H, Jeevan M, Saini DK, Singh A, Gupta D, Tripathi S. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples. EBioMedicine 2021;70:103525. [PMID: 34392148 DOI: 10.1016/j.ebiom.2021.103525] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 52 |
Mohanty SS, Sahoo CR, Padhy RN. Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19. AAPS PharmSciTech 2021;22:214. [PMID: 34378108 DOI: 10.1208/s12249-021-02089-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 53 |
Pal M, Musib D, Zade AJ, Chowdhury N, Roy M. Computational Studies of Selected Transition Metal Complexes as Potential Drug Candidates against the SARS-CoV-2 Virus. ChemistrySelect 2021;6:7429-35. [PMID: 34541296 DOI: 10.1002/slct.202101852] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 54 |
Anand K, Vadivalagan C, Joseph JS, Singh SK, Gulati M, Shahbaaz M, Abdellattif MH, Prasher P, Gupta G, Chellappan DK, Dua K. A novel nano therapeutic using convalescent plasma derived exosomal (CP(Exo)) for COVID-19: A combined hyperactive immune modulation and diagnostics. Chem Biol Interact 2021;344:109497. [PMID: 33991505 DOI: 10.1016/j.cbi.2021.109497] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 55 |
Sourimant J, Aggarwal M, Plemper RK. Progress and pitfalls of a year of drug repurposing screens against COVID-19. Curr Opin Virol 2021;49:183-93. [PMID: 34218010 DOI: 10.1016/j.coviro.2021.06.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 56 |
Hosseinzadeh A, Tavakolian A, Kia V, Ebrahimi H, Sheibani H, Binesh E, Jafari R, Mirrezaie SM, Jafarisani M, Emamian MH. Application of nasal spray containing dimethyl sulfoxide (DMSO) and ethanol during the COVID-19 pandemic may protect healthcare workers: A randomized controlled trials.. [DOI: 10.1101/2021.07.06.21259749] [Reference Citation Analysis]
|
| 57 |
Karges J, Cohen SM. Metal Complexes as Antiviral Agents for SARS-CoV-2. Chembiochem 2021;22:2600-7. [PMID: 34002456 DOI: 10.1002/cbic.202100186] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 58 |
Munteanu AC, Uivarosi V. Ruthenium Complexes in the Fight against Pathogenic Microorganisms. An Extensive Review. Pharmaceutics 2021;13:874. [PMID: 34199283 DOI: 10.3390/pharmaceutics13060874] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 59 |
Zafar W, Sumrra SH, Chohan ZH. A review: Pharmacological aspects of metal based 1,2,4-triazole derived Schiff bases. Eur J Med Chem 2021;222:113602. [PMID: 34139626 DOI: 10.1016/j.ejmech.2021.113602] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 60 |
Marzo T, La Mendola D. Strike a Balance: Between Metals and Non-Metals, Metalloids as a Source of Anti-Infective Agents. Inorganics 2021;9:46. [DOI: 10.3390/inorganics9060046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 61 |
Chuong C, DuChane CM, Webb EM, Rai P, Marano JM, Bernier CM, Merola JS, Weger-Lucarelli J. Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2. Viruses 2021;13:980. [PMID: 34070524 DOI: 10.3390/v13060980] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 62 |
Manček-Keber M, Hafner-Bratkovič I, Lainšček D, Benčina M, Govednik T, Orehek S, Plaper T, Jazbec V, Bergant V, Grass V, Pichlmair A, Jerala R. Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs. FASEB J 2021;35:e21651. [PMID: 34004056 DOI: 10.1096/fj.202100560R] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 63 |
Quentin-Froignant C, Kappler-Gratias S, Top S, Bertagnoli S, Gallardo F. ANCHOR-tagged equine herpesvirus 1: A new tool for monitoring viral infection and discovering new antiviral compounds. J Virol Methods 2021;294:114194. [PMID: 34022301 DOI: 10.1016/j.jviromet.2021.114194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 64 |
Azim F, Islam MS, Saju H, Fatema K, Hayat A, Kamal M, Sarfraz M, Muhammad N, Rizvi SA. The Emergence of Novel Coronavirus Disease, Global Treatment Update and its Containment Strategies in Overpopulated Countries: A Review. COVID 2021;2:1-10. [DOI: 10.2174/2666796701999201123101730] [Reference Citation Analysis]
|
| 65 |
Wang Z, Yang L. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts. J Ethnopharmacol 2021;270:113869. [PMID: 33485973 DOI: 10.1016/j.jep.2021.113869] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 24.5] [Reference Citation Analysis]
|
| 66 |
Peter AE, Sandeep BV, Rao BG, Kalpana VL. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Front Nanotechnol 2021;3:644023. [DOI: 10.3389/fnano.2021.644023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Wallis RS, Ginindza S, Beattie T, Arjun N, Likoti M, Edward VA, Rassool M, Ahmed K, Fielding K, Ahidjo BA, Vangu MDT, Churchyard G. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir Med 2021;9:897-908. [PMID: 33740465 DOI: 10.1016/S2213-2600(20)30448-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 68 |
Milani M, Donalisio M, Bonotto RM, Schneider E, Arduino I, Boni F, Lembo D, Marcello A, Mastrangelo E. Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. Antiviral Res 2021;189:105055. [PMID: 33713730 DOI: 10.1016/j.antiviral.2021.105055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 69 |
Smail SW, Saeed M, Twana Alkasalias, Khudhur ZO, Younus DA, Rajab MF, Abdulahad WH, Hussain HI, Niaz K, Safdar M. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review. Food Chem Toxicol 2021;150:112087. [PMID: 33640537 DOI: 10.1016/j.fct.2021.112087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 70 |
O'Donovan SM, Imami A, Eby H, Henkel ND, Creeden JF, Asah S, Zhang X, Wu X, Alnafisah R, Taylor RT, Reigle J, Thorman A, Shamsaei B, Meller J, McCullumsmith RE. Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach. Sci Rep 2021;11:4495. [PMID: 33627767 DOI: 10.1038/s41598-021-84044-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 71 |
Biji A, Khatun O, Swaraj S, Narayan R, Rajmani R, Sardar R, Satish D, Mehta S, Bindhu H, Jeevan M, Saini DK, Singh A, Gupta D, Tripathi S. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples.. [DOI: 10.1101/2021.02.18.431825] [Reference Citation Analysis]
|
| 72 |
Watashi K. Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches. Biochem Biophys Res Commun 2021;538:137-44. [PMID: 33272566 DOI: 10.1016/j.bbrc.2020.10.094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 73 |
Kumari P, Rothan HA, Natekar JP, Stone S, Pathak H, Strate PG, Arora K, Brinton MA, Kumar M. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Viruses 2021;13:132. [PMID: 33477869 DOI: 10.3390/v13010132] [Cited by in Crossref: 105] [Cited by in F6Publishing: 116] [Article Influence: 52.5] [Reference Citation Analysis]
|
| 74 |
Savosina PI, Druzhilovskii DS, Poroikov VV. COVID-19: Analysis of Drug Repositioning Practice. Pharm Chem J 2021;:1-8. [PMID: 33456092 DOI: 10.1007/s11094-021-02308-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 75 |
Sarkar PK, Das Mukhopadhyay C. Ayurvedic metal nanoparticles could be novel antiviral agents against SARS-CoV-2. Int Nano Lett 2021;:1-7. [PMID: 33425283 DOI: 10.1007/s40089-020-00323-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 76 |
Ghaffari M, Mollazadeh-Bajestani M, Moztarzadeh F, Uludağ H, Hardy JG, Mozafari M. An overview of the use of biomaterials, nanotechnology, and stem cells for detection and treatment of COVID-19: towards a framework to address future global pandemics. Emergent Mater 2021;:1-16. [PMID: 33426467 DOI: 10.1007/s42247-020-00143-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 77 |
Pinki, Subhash, Chaudhary A. Emerging Potential of Metallodrugs to Target Coronavirus: Efficacy, Toxicity and their Mechanism of Action. Asian J Chem 2021;33:1191-1207. [DOI: 10.14233/ajchem.2021.23228] [Reference Citation Analysis]
|
| 78 |
Armstrong LA, Lange SM, Dee Cesare V, Matthews SP, Nirujogi RS, Cole I, Hope A, Cunningham F, Toth R, Mukherjee R, Bojkova D, Gruber F, Gray D, Wyatt PG, Cinatl J, Dikic I, Davies P, Kulathu Y. Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies. PLoS One 2021;16:e0253364. [PMID: 34270554 DOI: 10.1371/journal.pone.0253364] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 79 |
Ahamad S, Branch S, Harrelson S, Hussain MK, Saquib M, Khan S. Primed for global coronavirus pandemic: Emerging research and clinical outcome. Eur J Med Chem 2021;209:112862. [PMID: 33070079 DOI: 10.1016/j.ejmech.2020.112862] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 80 |
Rouco L, Sánchez-González Á, Alvariño R, Alfonso A, Vázquez-López EM, García-Martínez E, Maneiro M. Combined Effect of Caspase-Dependent and Caspase-Independent Apoptosis in the Anticancer Activity of Gold Complexes with Phosphine and Benzimidazole Derivatives. Pharmaceuticals (Basel) 2020;14:10. [PMID: 33374177 DOI: 10.3390/ph14010010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 81 |
de Paiva REF, Marçal Neto A, Santos IA, Jardim ACG, Corbi PP, Bergamini FRG. What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks. Dalton Trans 2020;49:16004-33. [PMID: 33030464 DOI: 10.1039/d0dt02478c] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 82 |
Tarek M, Savarino A. Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention. Eur J Drug Metab Pharmacokinet 2020;45:715-23. [PMID: 32780273 DOI: 10.1007/s13318-020-00640-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 83 |
Anthony EJ, Bolitho EM, Bridgewater HE, Carter OWL, Donnelly JM, Imberti C, Lant EC, Lermyte F, Needham RJ, Palau M, Sadler PJ, Shi H, Wang FX, Zhang WY, Zhang Z. Metallodrugs are unique: opportunities and challenges of discovery and development. Chem Sci 2020;11:12888-917. [PMID: 34123239 DOI: 10.1039/d0sc04082g] [Cited by in Crossref: 175] [Cited by in F6Publishing: 182] [Article Influence: 58.3] [Reference Citation Analysis]
|
| 84 |
Misra S, Nath M, Hadda V, Vibha D. Efficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis. Eur J Clin Invest 2020;50:e13383. [PMID: 32810285 DOI: 10.1111/eci.13383] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 85 |
Kumari P, Singh A, Ngasainao MR, Shakeel I, Kumar S, Lal S, Singhal A, Sohal SS, Singh IK, Hassan MI. Potential diagnostics and therapeutic approaches in COVID-19. Clin Chim Acta 2020;510:488-97. [PMID: 32795547 DOI: 10.1016/j.cca.2020.08.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 86 |
Owji H, Negahdaripour M, Hajighahramani N. Immunotherapeutic approaches to curtail COVID-19. Int Immunopharmacol 2020;88:106924. [PMID: 32877828 DOI: 10.1016/j.intimp.2020.106924] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 87 |
Stenger‐smith JR, Mascharak PK. Gold Drugs with {Au(PPh 3 )} + Moiety: Advantages and Medicinal Applications. ChemMedChem 2020;15:2136-45. [DOI: 10.1002/cmdc.202000608] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 88 |
Suhail S, Zajac J, Fossum C, Lowater H, McCracken C, Severson N, Laatsch B, Narkiewicz-Jodko A, Johnson B, Liebau J, Bhattacharyya S, Hati S. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review. Protein J 2020;39:644-56. [PMID: 33106987 DOI: 10.1007/s10930-020-09935-8] [Cited by in Crossref: 109] [Cited by in F6Publishing: 123] [Article Influence: 36.3] [Reference Citation Analysis]
|
| 89 |
Gil-Moles M, Basu U, Büssing R, Hoffmeister H, Türck S, Varchmin A, Ott I. Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics*. Chemistry 2020;26:15140-4. [PMID: 32915473 DOI: 10.1002/chem.202004112] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 90 |
Ogando NS, Dalebout TJ, Zevenhoven-Dobbe JC, Limpens RWAL, van der Meer Y, Caly L, Druce J, de Vries JJC, Kikkert M, Bárcena M, Sidorov I, Snijder EJ. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J Gen Virol 2020;101:925-40. [PMID: 32568027 DOI: 10.1099/jgv.0.001453] [Cited by in Crossref: 313] [Cited by in F6Publishing: 326] [Article Influence: 104.3] [Reference Citation Analysis]
|
| 91 |
Cirri D, Pratesi A, Marzo T, Messori L. Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs. Expert Opin Drug Discov 2021;16:39-46. [PMID: 32915656 DOI: 10.1080/17460441.2020.1819236] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 92 |
Maiti BK. Can Papain-like Protease Inhibitors Halt SARS-CoV-2 Replication? ACS Pharmacol Transl Sci 2020;3:1017-9. [PMID: 33062954 DOI: 10.1021/acsptsci.0c00093] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 93 |
Wang Z, Yang L. Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection. Front Pharmacol 2020;11:1013. [PMID: 32714193 DOI: 10.3389/fphar.2020.01013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 94 |
Prasad A, Muthamilarasan M, Prasad M. Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules. Plant Cell Rep 2020;39:1109-14. [PMID: 32561979 DOI: 10.1007/s00299-020-02560-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 95 |
Marzo T, Messori L. A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin. ACS Med Chem Lett 2020;11:1067-8. [PMID: 32547693 DOI: 10.1021/acsmedchemlett.0c00190] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 96 |
Singh TU, Parida S, Lingaraju MC, Kesavan M, Kumar D, Singh RK. Drug repurposing approach to fight COVID-19. Pharmacol Rep 2020;72:1479-508. [PMID: 32889701 DOI: 10.1007/s43440-020-00155-6] [Cited by in Crossref: 220] [Cited by in F6Publishing: 219] [Article Influence: 73.3] [Reference Citation Analysis]
|
| 97 |
[DOI: 10.1101/2020.12.14.422714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
|
